Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Vaccination With Peptides From Anti-apoptotic Proteins in Relapsed Multiple Myeloma

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2009 by Herlev Hospital.
Recruitment status was:  Recruiting
Sponsor:
Collaborator:
Odense University Hospital
Information provided by:
Herlev Hospital
ClinicalTrials.gov Identifier:
NCT01272466
First received: January 3, 2011
Last updated: January 6, 2011
Last verified: May 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)